are nucleosides, which are being tested for the treatment of HIVand Herpes SimplexVirus infections. These nucleosides possess one chiral center, and were synthesised stereospecifically as a single enantiomer (R or S) by an asymmetric pathway. The chiral stationary phases chosen were silicabased amylose tris-3,5-dimethylphenylcarbamate (Chiralpak AD), and (t ris-(S)-1-phenylethylcarbamate (ChiralpakAS) respectively. The resolution was accomplished using normal phase methodology with a mobile phase consisting of n-hexane-alcohol (ethanol or 2-propanol) in various percentages. This paper describes the optimization of the chromatographic parameters and the determination of enantiomeric purity. Difference in hpophihcity for these compounds has been examined. The effect of structural features were thoroughly studied in relation to retention, selectivity, resolution and elution order.